Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytosine is one of the four major nitrogenous bases (pyrimidine class, chemical formula C₄H₅N₃O) present in DNA, where it forms stable hydrogen bonds with guanine through Watson-Crick base pairing. In eukaryotic cells, cytosine residues in DNA can be methylated at the 5-position to form 5-methylcytosine, an epigenetic modification that plays critical roles in gene regulation, development, and disease. Aberrant modification or mutagenic deamination of cytosine contributes to genome instability and is implicated in carcinogenesis and other diseases
Not applicable for cytosine residues directly\n(DNA methyltransferase inhibitors block methylation of cytosine residues in DNA, leading to changes in gene expression)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosine residue in DNA (C (when referring to DNA sequence notation); otherwise, none in this context).